$70.5B
$1.48 Million
0.01% of portfolio
1,124
Q3 2025
Added 311.72%
$23.5B
$1.08 Million
0.01% of portfolio
21,930
Q2 2025
Added 100.0%
$82.8B
$1.14 Million
0.01% of portfolio
8,671
Q1 2025
Reduced 3.55%
$17.4B
$1.41 Million
0.01% of portfolio
18,047
Q3 2025
Reduced 12.02%
$74B
$1.58 Million
0.01% of portfolio
19,278
Q2 2025
Reduced 0.05%
$15.3B
$1.38 Million
0.01% of portfolio
22,752
Q3 2025
Added 745.17%
$25.1B
$615,000
0.01% of portfolio
4,300
Q1 2025
Reduced 18.48%
$0
$946,000
0.01% of portfolio
15,790
Q1 2025
Added 5.52%
$301B
$1.16 Million
0.01% of portfolio
2,430
Q3 2025
Reduced 12.43%
$28.3B
$607,000
0.01% of portfolio
2,756
Q3 2025
Added 3.41%
$10.2B
$1.1 Million
0.01% of portfolio
24,514
Q3 2025
Added 21,593.81%
$25B
$621,000
0.01% of portfolio
3,725
Q1 2025
Reduced 0.75%
$0
$823,000
0.01% of portfolio
6,950
Q1 2021
Added 24.89%
$19.4B
$585,000
0.01% of portfolio
1,120
Q2 2024
Reduced 1.32%
$0
$683,000
0.01% of portfolio
9,570
Q1 2025
Added 35.36%
$44.6B
$654,000
0.01% of portfolio
9,682
Q3 2025
Reduced 7.01%
$177B
$1.15 Million
0.01% of portfolio
5,894
Q3 2025
Reduced 74.13%
$153B
$786,000
0.01% of portfolio
7,087
Q1 2025
Reduced 16.65%
$10.5B
$1.53 Million
0.01% of portfolio
26,530
Q3 2025
New
$38.8B
$944,000
0.01% of portfolio
9,790
Q3 2025
Added 614.6%
-
$0
0.0% of portfolio
-
Q3 2025
New
$15.6B
$6,000
0.0% of portfolio
48
Q3 2024
Reduced 68.63%
-
$0
0.0% of portfolio
-
Q3 2025
New
$26.5B
$500,000
0.0% of portfolio
915
Q3 2025
Added 9.58%
$3.12B
$0
0.0% of portfolio
10
Q3 2025
Reduced 99.67%
$9.71B
$176,000
0.0% of portfolio
4,680
Q2 2021
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 22.86%
$7.75B
$6,000
0.0% of portfolio
120
Q1 2022
Reduced 73.91%
$21.7B
$1,000
0.0% of portfolio
17
Q2 2023
Reduced 90.56%
$123B
$22,000
0.0% of portfolio
160
Q2 2025
New
$11.7B
$104,000
0.0% of portfolio
7,107
Q2 2024
Reduced 0.06%
Rigel Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
$36.2B
$4,000
0.0% of portfolio
17
Q2 2023
New
$16.6B
$561,000
0.0% of portfolio
2,000
Q3 2025
New
$197B
$157,000
0.0% of portfolio
1,605
Q3 2025
Reduced 23.75%
$69.3B
$132,000
0.0% of portfolio
2,735
Q4 2024
Reduced 5.43%
$154B
$202,000
0.0% of portfolio
540
Q2 2025
Reduced 4.09%
$14.5B
$468,000
0.0% of portfolio
2,640
Q3 2025
New
$35.9B
$40,000
0.0% of portfolio
666
Q1 2022
Reduced 86.61%
$21B
$19,000
0.0% of portfolio
200
Q3 2025
Reduced 50.0%
$0
$290,000
0.0% of portfolio
2,407
Q3 2025
Added 5.02%
$36.2B
$34,000
0.0% of portfolio
463
Q4 2024
New
$6.02B
$29,000
0.0% of portfolio
195
Q1 2025
Reduced 26.42%
$0
$183,000
0.0% of portfolio
462
Q1 2022
Reduced 26.78%
$66.2B
$34,000
0.0% of portfolio
200
Q2 2025
Reduced 42.86%
$4.31B
$265,000
0.0% of portfolio
10,000
Q2 2023
New
$0
$107,000
0.0% of portfolio
1,986
Q1 2025
Reduced 38.63%
$10.2B
$24,000
0.0% of portfolio
590
Q3 2024
Added 210.53%
$24.4B
$200,000
0.0% of portfolio
970
Q4 2022
Reduced 41.03%
$5.65B
$233,000
0.0% of portfolio
2,710
Q3 2025
Added 26.34%